+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Valdecoxib"

COX-2 Selective NSAIDs Market - Global Forecast 2026-2032 - Product Thumbnail Image

COX-2 Selective NSAIDs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 187 Pages
  • Global
From
Specific COX-2 Inhibitors Market - Global Forecast 2025-2030 - Product Thumbnail Image

Specific COX-2 Inhibitors Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 181 Pages
  • Global
From
Pain Therapeutics - Drugs, Markets and Companies - Product Thumbnail Image

Pain Therapeutics - Drugs, Markets and Companies

  • Report
  • November 2021
  • 600 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Valdecoxib is a non-steroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation. It is a member of the coxib class of drugs, which are selective inhibitors of the enzyme cyclooxygenase-2 (COX-2). Valdecoxib is used to treat mild to moderate pain, including menstrual pain, and to reduce fever. It is also used to treat osteoarthritis and rheumatoid arthritis. It is available in tablet form and is taken orally. Valdecoxib is a relatively new drug and is not as widely used as other NSAIDs. It is generally considered to be a safe and effective treatment for pain and inflammation, although it has been associated with an increased risk of cardiovascular events. Companies in the Valdecoxib market include Pfizer, Merck, and GlaxoSmithKline. Show Less Read more